Murine Kras-driven lung cancer models have confirmed the key requirements for RAF, PI3K and RAL-GEF in vivo. Co-opted pathways required by oncogenic KRAS in order to sustain lung tumorigenesis ...
Despite hotly debated biomarkers and failed or delayed confirmatory trials, the accelerated approval program has a track ...
A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...
Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, ...
Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...
Lung cancer is the third most common type of cancer diagnosed in the United States but is the deadliest cancer in our country ...
Hosted on MSN13d
'Invisible' cancer revealed to body in new researchResearchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.
The Lung Cancer Research Foundation (LCRF) and the International Association for the Study of Lung Cancer (IASLC) today ...
November is Lung Cancer Awareness Month, which serves as a good reminder of the resources available locally to help catch the ...
(HealthDay News) — Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer ...
Murine Kras-driven lung cancer models have confirmed the key requirements for RAF, PI3K and RAL-GEF in vivo. Co-opted pathways required by oncogenic KRAS in order to sustain lung tumorigenesis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback